Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARKS: PI vs NNRTI HAART for AIDS-related Kaposi's Sarcoma
NCT00444379Phase 4Completed
- Sponsor
- University of California, San Francisco
- Start
- Apr 2007
- Primary completion
- Feb 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of lopinavir + ritonavir in Kaposi's sarcoma (KS), sponsored by University of California, San Francisco. Started Apr 2007; status: completed.
02
Drugs
lopinavir + ritonavir
03
Conditions
Kaposi's sarcoma (KS)
Beyond the preview
Go deeper on NCT00444379.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00444379.